During the past few years IMS has aggressively built strong capabilities worldwide to support this highly competitive and fast-growing therapeutic class.
Our global team of experts combines best-in-class oncology expertise and unparalleled market insights to offer clients an integrated and cohesive approach to optimize the lifecycle of their oncology brands.
With unrivalled access to global information assets, Key Opinion Leaders and Stakeholder networks, we deliver significant value to clients—transforming evidence into optimal business decisions.
Today, we have more than 60 clinical and commercial oncology experts who are world-class leaders in:
- Competitive intelligence
- Market sizing and forecasting
- Brand positioning
- Pricing
- Market Access
- Health economics and outcomes research
Our experts have conducted more than 140 oncology engagements in solid and liquid tumors, major and niche cancers, as well as supportive care. Among our experts are: MDs (oncologists and surgeons), PhDs (specializing in oncology, gene therapy, biochemistry, virology and molecular biology, and PharmDs.
With 50+ years of industry experience, proven consulting capabilities, and world-class market analytics and insights, IMS can mobilize unequaled skill and resources from 100 countries to help clients drive decisions and shape strategies in the oncology market.